In an 18-month clinical trial of the experimental GLP-1 pill orforglipron, about 60 percent of people lost at least 10 ...

Eli Lilly, the maker of Zepbound and Mounjaro, said its experimental GLP-1 pill successfully helped adults with obesity lose weight in a Phase 3 trial, as the company moves closer to submitting the ...

In a clinical trial, the company's weight loss pill resulted in a nearly 12% weight loss at 72 weeks for participants who took the highest dose of the medication. On average, participants lost 7.8% to ...

The data hasn't been peer-reviewed yet but the drug company said their average patient lost 27 pounds in over 72 weeks.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Eli Lilly’s experimental oral GLP-1 medication, orforglipron, led to an average weight loss of 12.4%, or 27.3 pounds, in a phase 3 trial involving more than 3,000 adults.  Based on the results, the ...

AstraZeneca and Eccogene are advancing ECC5004, a once-daily GLP-1 receptor agonist pill. Early stage trial showed a ...

The White Sox have signed shortstop Billy Carlson, reports Jim Callis of MLB.com. The Sox selected Carlson with their first-round pick, 10th overall, in last week’s draft.

The White Sox made their first-round pick official on Tuesday by signing Billy Carlson for $6,235,900, as first reported by Jim Callis of MLB Pipeline.

The White House is introducing another rescissions package "soon" that will include cuts to education funding.